Company: IONQ
Filing Date: 2025-06-09
Form Type: 8-K
Source: 0001193125-25-137398
Chunk: 1

Company: IonQ, Inc.
Filing Date: 2025-06-09
Form: 8-K
Item: Item 1.01
Chunk 1
---
-yearanniversary of the Closing; (iii) more than 64% of the Common Stock received by such Founder prior to the three-year anniversary of the Closing; (iv) more than 76% of the Common Stock received by such Founder prior to the four-year anniversary of the Closing; and (v) more than 88% of the Common Stock received by such Founder prior to the five-year anniversary of the Closing. All of the Common Stock received by the Founders at Closing will be released from the lock-upupon the six-yearanniversary of the Closing.

The Agreement contains customary representations, warranties, covenants and other obligations and rights of the parties thereto. The Agreement also specifies the treatment of outstanding Oxford Ionics options and equity awards in connection with the Transaction. The parties to the Agreement have also agreed to various customary covenants and agreements, including, among others, for Oxford Ionics to conduct, subject to certain exceptions, its business in the ordinary course consistent with past practice during the period between the execution of the Agreement and the Closing.

The completion of the Transaction is subject to the satisfaction of customary closing conditions, including, among other things, the absence of any governmental law or order that makes the Transaction illegal or otherwise prohibits or prevents its consummation; the obtainment, expiration, or termination (as applicable) of certain regulatory approvals imposed by governmental entities; the accuracy of the representations and warranties made by the parties to the Agreement (subject to customary materiality thresholds); no Material Adverse Effect has occured; and the authorization for listing of the Common Stock to be issued pursuant to the Agreement on the New York Stock Exchange.

The Agreement may be terminated under certain circumstances, including, but not limited to, by mutual written agreement of the Company and Oxford Ionics, and, subject to certain conditions, if the Closing shall not have occurred by March 7, 2026.

The foregoing description of the Transaction and the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, a copy of which is filed as Exhibit 2.1 to this Current Report on Form8-Kand is incorporated herein by reference. The Agreement has been filed to provide investors and security holders with information regarding its terms. The Agreement is not intended to provide any other factual or financial information about the Company, Oxford Ionics or their respective subsidiaries and affiliates. The representations, warranties and covenants contained in the Agreement were made only for purposes of that Agreement and as of specific dates; were solely for